产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确) |
别称 | Ovcar-3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR.3; OVCAR3; Ovcar3 |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
背景描述 | NIH:OVCAR-3 [OVCAR3]细胞是由T·C·Hamilton在1982年建系,NIH:OVCAR-3 [OVCAR3]细胞取材于患进行性卵巢腺癌病人的恶性腹水。在裸鼠皮下接种 1×10^7细胞,21天后全部成瘤。NIH:OVCAR-3 [OVCAR3]细胞是研究卵巢癌药物抗性的一个合适的模型系统且由于存在激素受体,这对于激素治疗的评估或许是有用的。 |
年龄(性别) | 女性;60岁 |
组织来源 | 卵巢腺癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 卵巢癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~35-64 hours |
致瘤性 | Yes, Forms colonies in soft agar.Yes, in nude mice inoculated subcutaneously with 1×10^7 cells (Tumors developed within 21 days at 100% frequency (5/5)). |
受体表达情况 | Androgen receptor, positive;estrogen receptor, positive;progesterone receptor, positive |
保藏机构 | ATCC; HTB-161 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 11,12 D2S1338 17,21 D3S1358 17,18 D5S818 11,12 D7S820 10 D8S1179 10,15 D13S317 12 D16S539 12 D18S51 13 D19S433 14,16.2 D21S11 29,31.2 FGA 21 PentaD 12,13 PentaE 7,13 TH01 9 TPOX 8 vWA 17 D6S1043 10,11 D12S391 19,22 D2S441 11,14 -
STR鉴定图
参考文献
-
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression(2023/10/12)
作者:Yanan Pi, Qiushi Feng, Fusheng Sun
期刊:CELL DEATH AND DIFFERENTIATION
DOI:10.1038/s41418-023-01226-w
影响因子 :12.400
引用产品:CL-0178
-
Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer(2024/02/26)
作者:Weisong Li, Kai Zhang, Wenjun Wang
期刊:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
DOI:10.1186/s13046-024-02981-5
影响因子 :11.300
引用产品:CL-0178
-
MiR-337–3p suppresses proliferation of epithelial ovarian cancer bytargeting PIK3CA and PIK3CB(2019/10/17)
作者:Zhen Zhang, Luoyan Zhang, Bin Wang
期刊:Cancer Letters
DOI:10.1016/j.canlet.2019.10.021
影响因子 :9.700
-
circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis(2022/10/22)
作者:Huiping Ma, Shuyun Qu, Yao Zhai
期刊:CELLULAR & MOLECULAR BIOLOGY LETTERS
DOI:10.1186/s11658-022-00364-2
影响因子 :8.300
-
A 19F NMR probe for the detection of β-galactosidase: simple structure with low molecular weight of 274.2, “turn-on” signal without the background, and good performance applicable in cancer cell line(2017/06/28)
作者:Jie Hu, Qiong Wu, Kai Cheng
期刊:J Mater Chem B
影响因子 :7.571
引用产品:CL-0178
-
Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression(2021/06/17)
作者:Tingting Gong, Qian Guo, Xiao Li
期刊:Biomedicine & Pharmacotherapy
DOI:10.1016/j.biopha.2021.111533
影响因子 :7.500
-
m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway(2024/01/29)
作者:Yan Li, Shenghan Lou, Jian Zhang
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-024-04929-x
影响因子 :7.400
引用产品:CL-0178
-
Dietary flavonoid tectochrysin synergistically enhances cisplatin sensitivity on ovarian cancer cells through targeting the CDK1/cyclin B1 pathway(2024/05/21)
作者:Shasha Liu, Yuling Guo, Feiya Jiang
期刊:Journal of Functional Foods
影响因子 :5.600
引用产品:CL-0178
-
MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer(2021/04/17)
作者:Mengqi Deng, Di Wu, Yanqin Zhang
期刊:Gynecologic Oncology
DOI:10.1016/j.ygyno.2021.04.013
影响因子 :4.700
-
Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53(2024/02/04)
作者:Zhaofeng Liu, Yifei Yang, Xiaohui Sun
期刊:MOLECULES
影响因子 :4.600
引用产品:CL-0178
-
CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis(2021/08/31)
作者:Wenwen Wang, Weiwei Zhang, Hongjun Guo
期刊:Cell Cycle
DOI:10.1080/15384101.2021.1965723
影响因子 :4.300
-
Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)(2023/04/22)
作者:Yaoyun Duan, Juan Yu, Miaojuan Chen
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-023-01156-8
影响因子 :4.000
-
CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells(2024/03/27)
作者:Qingsong Zhang, Rong Zhang, Yuzhi Li, Xiaojun Yang
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-024-01393-5
影响因子 :4.000
引用产品:CL-0178
-
The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1(2024/04/08)
作者:Yifei Ma, Hui Zong, Pan Pan
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2024.114006
影响因子 :3.700
引用产品:CL-0178
-
MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo(2024/01/08)
作者:Yun Zhang, Fanglin Liu, Jindan Zheng
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2024.113913
影响因子 :3.700
引用产品:CL-0178
-
Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives(2023/11/27)
作者:Yan Li, Liang Meng, Ge Lou
期刊:CANCER BIOLOGY & THERAPY
DOI:10.1080/15384047.2023.2285817
影响因子 :3.600
引用产品:CL-0178
-
Norcantharidin induces ferroptosis via the suppression of NRF2/HO‑1 signaling in ovarian cancer cells(2022/08/25)
作者:Xiaoyan Zhu, Xiaohong Chen, Longshan Qiu
期刊:Oncology Letters
影响因子 :2.900
-
ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer(2023/11/03)
作者:Yue Deng, Ying Dong, Lu Wu
期刊:PATHOLOGY RESEARCH AND PRACTICE
影响因子 :2.800
引用产品:CL-0178
-
miR‑638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells(2021/9/20)
作者:Li Ma, Wei Zhang, Yaofeng Jin
期刊:Experimental and Therapeutic Medicine
影响因子 :2.700
-
Down-regulation of DPP4 by TGFβ1/miR29a-3p inhibited proliferation and promoted migration of ovarian cancer cells(2023/10/31)
作者:Chong Liu, Zhaowei Gao, Yingqi Liu
期刊:Discover Oncology
DOI:10.1007/s12672-023-00815-y
影响因子 :2.200
引用产品:CL-0178
-
MOB kinase activator 1A acts as an oncogene by targeting PI3K/AKT/mTOR in ovarian cancer(2023/06/14)
作者:Jian Lei, Jingying Xu, Min Hu
期刊:Discover Oncology
DOI:10.1007/s12672-023-00705-3
影响因子 :2.200
引用产品:CL-0178
-
Circ_0021573 acts as a competing endogenous RNA to promote the malignant phenotypes of human ovarian cancer cells(2022/12/05)
作者:Lifang Liu, Bingkai Han, Lixia Liu
期刊:Reproductive Biology
DOI:10.1016/j.repbio.2022.100704
影响因子 :2.100
引用产品:164210 164210-50 CL-0005 CL-0079 CL-0178 CL-0215 PB180120 PM150110
-
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib(2022/09/05)
作者:Xiaocui Zhang, Meige Sun, Yisheng Jiao
期刊:Oxidative Medicine and Cellular Longevity
影响因子 :0.000
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图